Table 3.
Name | Structure | Molecular Function(s) | Ref. |
---|---|---|---|
AG1478 | EGFR tyrosine kinase inhibitor | Zhang et al., 2011 | |
Ascorbic acid | Multiple |
Takahashi et al., 2003 Cao et al., 2012 |
|
BMS-189453 | Pan-retinoic acid receptor antagonist | Zhang et al., 2011 | |
Cardiogenol C | Unknown | Wu et al., 2004 | |
Cinchona alkaloid derivative | Unknown | Berkessel et al., 2010 | |
Diazoxide | ATP-sensitive activator K+ channel | Niagara et al., 2007 | |
1-EBIO | Agonist of Ca2+-activated K+ channels | Kleger et al., 2010 | |
Isoxazolyl-serine derivative | PPAR agonist | Wei et al., 2004 | |
Isx1 (isoxazole) | Cardiac muscle gene activator. Neuronal reporter genes activator. |
Russell et al., 2013 | |
IWR-1-endo | Wnt inhibitor | Gonzalez et al., 2011 | |
IWP-2 | Wnt inhibitor | Lian et al., 2012 | |
IWP-4 | Wnt inhibitor | Lian et al., 2012 | |
KY02111 | Wnt inhibitor | Minami et al., 2012 | |
Pinacidil | ATP-dependent K+ channel opener | Laflamme et al., 2007 | |
Pioglitazone | PPAR-γ activator | Shinmura et al., 2011 | |
Purmorphamine | Sonic Hedgehog signaling agonist | Gonzalez et al., 2011 | |
RA | Natural ligand of RA receptors | Zhang et al., 2011 | |
SB203580 | p38 MAPK inhibitor | Graichen et al., 2008 | |
Shz-1 (sulfonylhydrazone) | Activator of gene Nkx2.5 | Sadek et al., 2008 | |
Verapamil | L-type Ca2+ channel blocker | Sachinidis et al., 2006 | |
ZVAD-fmk | Caspase inhibitor | Laflamme et al., 2007 |